Correlation Between 4D Molecular and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Esperion Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Esperion Therapeutics.
Diversification Opportunities for 4D Molecular and Esperion Therapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between FDMT and Esperion is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between 4D Molecular and Esperion Therapeutics
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Esperion Therapeutics. In addition to that, 4D Molecular is 1.18 times more volatile than Esperion Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 224.00 in Esperion Therapeutics on September 1, 2024 and sell it today you would earn a total of 56.00 from holding Esperion Therapeutics or generate 25.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
4D Molecular Therapeutics vs. Esperion Therapeutics
Performance |
Timeline |
4D Molecular Therapeutics |
Esperion Therapeutics |
4D Molecular and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 4D Molecular and Esperion Therapeutics
The main advantage of trading using opposite 4D Molecular and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.4D Molecular vs. Tff Pharmaceuticals | 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. Inhibrx | 4D Molecular vs. Enliven Therapeutics |
Esperion Therapeutics vs. Tff Pharmaceuticals | Esperion Therapeutics vs. Eliem Therapeutics | Esperion Therapeutics vs. Inhibrx | Esperion Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |